Jyong Biotech MENS
NASDAQ MENS
$1.74 -0.15 (-7.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Notes Payables (2024 - 2025)

Updated

Jyong Biotech's Notes Payables came in at $7.71 million for the quarter ended Dec 31, 2025, up 6.7% from $7.23 million a year earlier.

Analysis

Jyong Biotech (MENS) Notes Payables (2024 - 2025) Analysis & Trends

  • Going back by year, Notes Payables was $7.23 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Jyong Biotech 121.38 Mn 121.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 7.71 Mn
Jun 30, 2025 22.44 Mn
Dec 31, 2024 7.23 Mn
API Access

Jyong Biotech Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=MENS&period=max&api_key=YOUR_API_KEY